INR 701.9
(1.52%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -706.14 Million INR | 45.94% |
2022 | -2.3 Billion INR | 51.31% |
2021 | -4.74 Billion INR | -276.67% |
2020 | 2.68 Billion INR | 637.66% |
2019 | 363.91 Million INR | -88.79% |
2018 | 3.24 Billion INR | -50.85% |
2017 | 6.6 Billion INR | 65.22% |
2016 | 3.99 Billion INR | 91.33% |
2015 | 2.08 Billion INR | -75.27% |
2014 | 8.44 Billion INR | 552.58% |
2013 | -1.86 Billion INR | -122.06% |
2012 | 8.46 Billion INR | 276.98% |
2011 | 2.24 Billion INR | 83.32% |
2010 | 1.22 Billion INR | 11.64% |
2009 | 1.09 Billion INR | 1.59% |
2008 | 1.07 Billion INR | 315.4% |
2007 | -501.21 Million INR | -224.59% |
2006 | 402.29 Million INR | -17.16% |
2005 | 485.64 Million INR | 10.38% |
2004 | 439.98 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | 702.02 Million INR | 286.26% |
2024 Q2 | 932.32 Million INR | 32.81% |
2023 FY | -1.24 Billion INR | 45.94% |
2023 Q4 | 181.75 Million INR | -63.41% |
2023 Q3 | 496.67 Million INR | 137.81% |
2023 Q2 | -1.31 Billion INR | -1746.52% |
2023 Q1 | -71.13 Million INR | 48.44% |
2022 FY | -2.3 Billion INR | 51.31% |
2022 Q2 | 3.32 Million INR | 100.25% |
2022 Q4 | -137.95 Million INR | 83.2% |
2022 Q3 | -821.06 Million INR | -24830.72% |
2022 Q1 | -1.35 Billion INR | -563.16% |
2021 Q3 | -1.21 Billion INR | 25.15% |
2021 Q1 | -2.05 Billion INR | -545.25% |
2021 FY | -4.74 Billion INR | -276.67% |
2021 Q2 | -1.62 Billion INR | 20.78% |
2021 Q4 | 292.19 Million INR | 124.01% |
2020 Q2 | 809.45 Million INR | -21.84% |
2020 Q3 | 378.47 Million INR | -53.24% |
2020 Q4 | 460.86 Million INR | 21.77% |
2020 Q1 | 1.03 Billion INR | 150.79% |
2020 FY | 2.68 Billion INR | 637.66% |
2019 Q1 | 37 Million INR | -90.62% |
2019 FY | 363.91 Million INR | -88.79% |
2019 Q4 | -2.03 Billion INR | -317.19% |
2019 Q3 | 938.9 Million INR | -34.21% |
2019 Q2 | 1.42 Billion INR | 3757.3% |
2018 Q3 | 2.96 Billion INR | 2568.19% |
2018 Q2 | -120.1 Million INR | -103.21% |
2018 Q1 | -59.1 Million INR | -101.02% |
2018 FY | 3.24 Billion INR | -50.85% |
2018 Q4 | 394.48 Million INR | -86.69% |
2017 FY | 6.6 Billion INR | 65.22% |
2017 Q4 | 5.76 Billion INR | 598.28% |
2017 Q3 | 825.9 Million INR | 988.14% |
2017 Q2 | 75.9 Million INR | 1255.36% |
2017 Q1 | 5.6 Million INR | -99.5% |
2016 Q1 | 260.4 Million INR | 67.14% |
2016 Q4 | 1.12 Billion INR | -40.04% |
2016 Q3 | 1.87 Billion INR | 152.83% |
2016 Q2 | 740.9 Million INR | 184.52% |
2016 FY | 3.99 Billion INR | 91.33% |
2015 Q2 | 189.79 Million INR | 78.71% |
2015 Q1 | 106.2 Million INR | -6.82% |
2015 FY | 2.08 Billion INR | -75.27% |
2015 Q4 | 155.8 Million INR | -69.96% |
2015 Q3 | 518.63 Million INR | 173.26% |
2014 Q3 | 190.43 Million INR | 144.75% |
2014 Q2 | -425.57 Million INR | -324.15% |
2014 Q1 | 189.85 Million INR | 0.0% |
2014 FY | 8.44 Billion INR | 552.58% |
2014 Q4 | 113.97 Million INR | -40.15% |
2013 FY | -1.86 Billion INR | -122.06% |
2012 FY | 8.46 Billion INR | 276.98% |
2011 FY | 2.24 Billion INR | 83.32% |
2010 FY | 1.22 Billion INR | 11.64% |
2009 FY | 1.09 Billion INR | 1.59% |
2008 FY | 1.07 Billion INR | 315.4% |
2007 FY | -501.21 Million INR | -224.59% |
2006 FY | 402.29 Million INR | -17.16% |
2005 FY | 485.64 Million INR | 10.38% |
2004 FY | 439.98 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Sigachi Industries Limited | 571.8 Million INR | 223.494% |
Ind-Swift Limited | 142.31 Million INR | 596.188% |
Bajaj HealthCare Limited | -837.93 Million INR | 15.728% |
Sakar Healthcare Limited | 116.7 Million INR | 705.043% |
Aurobindo Pharma Limited | 31.72 Billion INR | 102.225% |
Innova Captab Limited | 943.45 Million INR | 174.847% |
Divi's Laboratories Limited | 16 Billion INR | 104.413% |
AstraZeneca Pharma India Limited | 1.61 Billion INR | 143.721% |
Morepen Laboratories Limited | 961.59 Million INR | 173.434% |
Mankind Pharma Limited | 19.12 Billion INR | 103.691% |
Sequent Scientific Limited | -358.69 Million INR | -96.866% |
Wanbury Limited | 559.56 Million INR | 226.195% |
Laurus Labs Limited | 1.6 Billion INR | 143.983% |
Nectar Lifesciences Limited | 49.95 Million INR | 1513.694% |
Glenmark Life Sciences Limited | 4.7 Billion INR | 114.996% |
Alembic Limited | 2.68 Billion INR | 126.288% |
Hikal Limited | 696 Million INR | 201.457% |
Alembic Pharmaceuticals Limited | 6.15 Billion INR | 111.467% |
Neuland Laboratories Limited | 3 Billion INR | 123.532% |
J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 112.778% |
Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 95.298% |
IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 152.528% |
Themis Medicare Limited | 435.23 Million INR | 262.242% |
RPG Life Sciences Limited | 876.6 Million INR | 180.554% |
Zydus Lifesciences Limited | 38.59 Billion INR | 101.83% |
Lupin Limited | 19.14 Billion INR | 103.688% |
Amrutanjan Health Care Limited | 449.72 Million INR | 257.016% |
Wockhardt Limited | -4.63 Billion INR | 84.749% |
Vaishali Pharma Limited | 7.18 Million INR | 9922.507% |
Aarti Pharmalabs Limited | 2.16 Billion INR | 132.556% |
Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 414.357% |
Jubilant Pharmova Limited | 771 Million INR | 191.588% |
FDC Limited | 3.05 Billion INR | 123.135% |
Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 101.268% |
Kilitch Drugs (India) Limited | 146.01 Million INR | 583.611% |
Eris Lifesciences Limited | 3.91 Billion INR | 118.015% |
Venus Remedies Limited | 284.9 Million INR | 347.848% |
ZIM Laboratories Limited | 172.46 Million INR | 509.442% |
Bliss GVS Pharma Limited | 754.54 Million INR | 193.585% |
Par Drugs and Chemicals Limited | 145.01 Million INR | 586.96% |
Caplin Point Laboratories Limited | 4.57 Billion INR | 115.449% |
Shilpa Medicare Limited | 318.74 Million INR | 321.54% |
Albert David Limited | 754.2 Million INR | 193.628% |
Ajanta Pharma Limited | 8.16 Billion INR | 108.652% |
Hester Biosciences Limited | 188.89 Million INR | 473.837% |
Suven Pharmaceuticals Limited | 3 Billion INR | 123.516% |
Solara Active Pharma Sciences Limited | -5.67 Billion INR | 87.555% |
Gufic Biosciences Limited | 861.35 Million INR | 181.98% |
Windlas Biotech Limited | 581.87 Million INR | 221.357% |
Procter & Gamble Health Limited | 2 Billion INR | 135.135% |
Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | 1607.665% |
Mangalam Drugs & Organics Limited | -90.71 Million INR | -678.399% |
Granules India Limited | 4.05 Billion INR | 117.422% |
Aarti Drugs Limited | 1.71 Billion INR | 141.194% |
Bal Pharma Limited | 73.92 Million INR | 1055.25% |
Alkem Laboratories Limited | 17.95 Billion INR | 103.932% |
Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 100.737% |
Lincoln Pharmaceuticals Limited | 933.04 Million INR | 175.681% |
Medicamen Biotech Limited | 109.31 Million INR | 745.998% |
Unichem Laboratories Limited | -704.74 Million INR | -0.198% |
Bafna Pharmaceuticals Limited | 73.47 Million INR | 1061.009% |
Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 10056.853% |
Valiant Laboratories Limited | 3.19 Million INR | 22194.493% |
Orchid Pharma Limited | 921.66 Million INR | 176.616% |
Medico Remedies Limited | 82.9 Million INR | 951.705% |
Ind-Swift Laboratories Limited | 4.2 Billion INR | 116.774% |
Ipca Laboratories Limited | 5.47 Billion INR | 112.901% |
Brooks Laboratories Limited | -195.91 Million INR | -260.424% |
Syncom Formulations (India) Limited | 253.14 Million INR | 378.95% |
Piramal Enterprises Limited | -16.83 Billion INR | 95.806% |
Torrent Pharmaceuticals Limited | 16.56 Billion INR | 104.263% |
NATCO Pharma Limited | 13.88 Billion INR | 105.086% |
Suven Life Sciences Limited | -1.05 Billion INR | 32.797% |
Krebs Biochemicals & Industries Limited | -197.28 Million INR | -257.931% |
Indoco Remedies Limited | 984.6 Million INR | 171.718% |
Alpa Laboratories Limited | 167.76 Million INR | 520.91% |
Lasa Supergenerics Limited | -217.3 Million INR | -224.952% |
Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 81.764% |